Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.
about
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesWarfarin reversalSMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375]Warfarin pharmacogenetics: does more accurate dosing benefit patients?Stroke prophylaxis in institutionalized elderly patients with atrial fibrillationRenal manifestations of the antiphospholipid syndromeDoes the Birmingham model of oral anticoagulation management in primary care work outside trial conditions?Anticoagulation therapy and primary care internal medicine: a nurse practitioner model for combined clinical science.Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage riskA role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Antithrombotic therapy for prosthetic valves: routine treatment and special considerations.Is admission for epistaxis more common in Caucasian than in Asian people? A preliminary study.Measurement of bleeding severity: a critical review.Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).A test of financial incentives to improve warfarin adherencePolypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismIncidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications.Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials.Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Intracerebral haemorrhages and oral anticoagulation in the north of Scotland.Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages.Diet as prophylaxis and treatment for venous thromboembolism?Long-term treatment with warfarin in Chinese population.Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.Pharmacogenetics of anticoagulants.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Pharmacogenetic association study of warfarin safety endpoints in Puerto RicansThe influence of age, liver size and enantiomer concentrations on warfarin requirements.The management of coumarin-induced over-anticoagulation Annotation.Antithrombotic therapy in cardiac embolism.A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation.Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: endoscopic findings, clinical management and outcome.The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.Risk of major hemorrhage for outpatients treated with warfarin.Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.Genotype and risk of major bleeding during warfarin treatment.Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.
P2860
Q24633053-76A65F83-57EC-47B1-9D03-4864ABE38454Q24672566-4701F0D7-6653-4B88-9A34-0D0C20F9D1DEQ24805990-1EF9427A-46CF-460A-B10E-3BC1C56865F6Q27027304-E018F0AC-6E23-4F0D-BE76-8BCCA3002956Q28167221-DD2991D3-9B67-41CA-97DF-E0954C478062Q28307709-F7806881-F5C3-4056-93D1-F0EC74087EB7Q28362511-6108410D-3167-49D4-A97A-84EADA515C82Q30465908-0385CAD7-48AB-4960-9075-FF91DE49BD2EQ30570918-901D3192-C5D0-4686-85F1-5A07E50FDE46Q30996878-1FA9BB7E-AFC2-4160-82E7-A6F73E7622ACQ31805137-F818DF66-EEAE-499D-9F71-C904D2677A86Q33259079-62F0B71B-CD67-4736-8D4B-7EAC87217F3CQ33360118-63421F00-9ED6-42D2-8A00-EEE19FD7A2E5Q33367685-15619DCA-FF06-45E5-AE5C-5D910EBDF919Q33395146-22F96E08-CB28-491B-B771-740ED13A7254Q33417203-48C2BEE2-C131-43F8-B612-39951CCC0655Q33585000-B1D29E9E-E4ED-4B91-89CA-C5F5FCE7CA99Q33651497-7B0506D6-ADC6-4186-BD5F-E9ACA59C91A6Q33917883-B42B0F6D-93D9-4D6A-9225-BD1E596EBB5EQ33943678-8930B863-6808-4605-A358-F73CE31C4B3AQ33978811-8F717A07-6B9B-46D4-B840-D68DC08EDE60Q34053704-A591F74C-D917-4EA5-A963-5B8AE725A8B1Q34075223-E5A4A842-0CE9-4FDB-962F-2EF3FC5311D4Q34075227-86A54F88-1451-485D-876B-11F60468045EQ34078303-340B5B41-54BE-464B-9EA1-7D1012BD4029Q34122505-F2C5F811-F144-4CA6-9C19-7582A5BE8B54Q34181658-1F34FFC1-D451-44DE-98C3-680BD41193B8Q34219746-0164BDBA-666E-47FB-ADF9-C675E7AB37C9Q34252907-EA24754A-61E6-48B5-905C-1C80239D0E0FQ34337948-DA341B12-6061-48FD-8EEF-6274F396A5B5Q34347371-809E08E0-6820-48BC-AC3F-494628D9A5BDQ34351118-C11F1E0F-5CC7-4EB7-8883-72A1A42A20CEQ34362901-FC0BAAD9-8FC8-462E-811A-5C48EEE42681Q34472581-3A0A923D-1D3C-4519-9A2E-F6C943EBF09BQ34605134-7E5EEF59-09CD-47E8-9835-4F13568998DDQ34744781-F4A104A3-31F4-4365-BA7E-2F64D5B04EBDQ34751905-A4E59DC4-9363-4266-A5A0-2F8C426A3148Q34834319-6C378DF6-B6AC-465B-8EBD-0EE12245B7B7Q35006973-5EF14248-78EB-458E-9651-0366619A9A8FQ35016262-5F9F71C2-E8B4-4A7C-82E9-EA9C3B5F9861
P2860
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Risk factors for complications ...... patient Follow-up Study Group.
@en
Risk factors for complications ...... patient Follow-up Study Group.
@nl
type
label
Risk factors for complications ...... patient Follow-up Study Group.
@en
Risk factors for complications ...... patient Follow-up Study Group.
@nl
prefLabel
Risk factors for complications ...... patient Follow-up Study Group.
@en
Risk factors for complications ...... patient Follow-up Study Group.
@nl
P2093
P1476
Risk factors for complications ...... patient Follow-up Study Group.
@en
P2093
Henikoff J
McDonell M
P304
P356
10.7326/0003-4819-118-7-199304010-00005
P407
P577
1993-04-01T00:00:00Z